NPC1L1 |
Frameshift, non-sense and splice-site mutations |
Coronary heart disease |
59 |
APOC3 |
Null mutation |
Ischemic vascular disease |
60 |
SLC30A8 |
Non-sense mutations |
Type II diabetes |
19 |
LPA |
Splice-site mutations |
Cardiovascular diseases |
18 |
APP |
Missense mutation |
Alzheimer's disease and age-related cognitive decline |
61 |
PCSK9 |
Non-sense and missense mutations |
Coronary heart disease |
20 |
Caspase12 |
Gene deletion |
Sepsis |
62 |
CCR-5 |
Deletion leading to frameshift mutation |
HIV-1 infection |
63 |
TYK2 |
Missense mutations |
Rheumatoid arthritis, systemic lupus erythematosus |
64 |
IFIH1 |
Missense and non-sense mutations |
Type 1 diabetes |
65 |
CARD9 |
Splice-site mutation |
Inflammatory bowel diseases (IBD) |
66 |
RNF186 |
Non-sense mutation |
Ulcerative colitis |
67 |
CD33 |
Increase in non-functional splice variant |
Alzheimer's disease and age-related cognitive decline |
This paper |